Project Grant HT94252310487
Award Date
6/15/23
Completion Date
6/14/27
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Department of the Army Medical Command awarded a $409,121 project grant to the Rochester Institute of Technology under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the development of a novel 3D scleroderma skin model to test therapeutic modulation of TRPC6 from July 2022 through July 2025. Through this research, the awardee aims to advance the development of medical solutions for the battlefield by investigating potential treatments for...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Defense Health Agency awarded a $4.66 million project grant to the University of Colorado Denver to support research on a stem cell-based therapy for recessive dystrophic epidermolysis bullosa delivered with a spray-on skin device. The grant was awarded on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420) and will run through August 31, 2027. Through this funding, the University of Colorado Denver will conduct research to develop an innovative...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and...
The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
This $293,500 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on clinical variation in epidermolysis bullosa, a rare genetic skin condition, and its implications for wound healing. The award, with a performance period from April 1, 2025 to March 31, 2027, is funding the Tel Aviv Medical Center in Israel to conduct this innovative scientific study. The research aims to uncover a new layer of complexity in...
The Department of Defense's Defense Health Agency awarded a $392,829 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant will fund a pilot study on "Skin Adaptation to Initial Prosthesis Use in Individuals with Lower Limb Amputation" over a 2-year period from August 1, 2024 to July 31, 2026.
As part of this project, the Foundation will collaborate with the...
The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...